

A third booster dose of a COVID-19 vaccine from either AstraZeneca Plc (NASDAQ: AZN), Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ:
You can purchase shares of Sinovac Biotech (NASDAQ:SVA) through any online brokerage.
Other companies in Sinovac Biotech’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Sinovac Biotech has a consensus price target of $1.00.
The stock price for Sinovac Biotech (NASDAQ: SVA) is $5.85 last updated December 31, 1969 at 7:00 PM EST.
There are no upcoming dividends for Sinovac Biotech.
Sinovac Biotech does not have any upcoming earnings scheduled.
There is no upcoming split for Sinovac Biotech.
Sinovac Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sinovac Biotech Ltd is a fully integrated China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of vaccines for the prevention of human infectious diseases, including certain diseases with...